Drug makers may profit from disease in global warming scourge

on

A report by PricewaterhouseCoopers LLP forecast that higher temperatures could lead to a doubling of the world pharmaceutical market in 13 years , with sales of medicines increasing to $1.3 trillion US from about $600 billion last year – provided drug makers find innovative treatments.

The New York-based accounting and consulting company, citing the Intergovernmental Panel on Climate Change, said the average temperature is projected to increase by 0.4 degrees Celsius during the next two decades and the increase could be greater if greenhouse-gas emissions increase.

Climate change may already be playing a role in reports of malaria in countries such as Turkey and Georgia where it was eradicated, the report said.

Related Posts

on

A new study adds to a growing body of evidence that fracking represents a “public health crisis,” experts say.

A new study adds to a growing body of evidence that fracking represents a “public health crisis,” experts say.
on

Cheniere Energy has introduced “cargo emissions tags” to assuage climate concerns of potential buyers. But a new report says these tags are riddled with problems.

Cheniere Energy has introduced “cargo emissions tags” to assuage climate concerns of potential buyers. But a new report says these tags are riddled with problems.
Opinion
on

Anti-science rhetoric and special interests have pushed us to the edge of climate chaos. But just as quantum physics disrupted our view of matter and energy, quantum social change disrupts our beliefs about what’s possible, how fast, and by whom.

Anti-science rhetoric and special interests have pushed us to the edge of climate chaos. But just as quantum physics disrupted our view of matter and energy, quantum social change disrupts our beliefs about what’s possible, how fast, and by whom.
on

Climate campaigners are concerned over Jane Toogood’s role in a company that sells technology to produce hydrogen from methane.

Climate campaigners are concerned over Jane Toogood’s role in a company that sells technology to produce hydrogen from methane.